Article Topic
“Reducing costs requires more than all of this non–value-added activity,” Expert Says
In this October 23, 2020 editorial, which was published in the The American Journal of Managed Care, Michael Abrams explains why drug importation will not save patients money. Abrams is the co-founder and managing partner of Numerof & Associates.
[...]Counterfeit Medicine: Crime and Policy, October 20, 2020
A summary briefing of 2020’s major cases, worrying trends and a deep dive into drug supply chain policy issues.
[...]Counterfeit Medicine News for the Week of October 12, 2020
In PSM’s round-up this week: new reports about counterfeit medicine, drug supply chain regulation and phishing scams; FDA warnings about dangerous supplements; a life sentence for fake pill kingpin Aaron Shamo; and more.
[...]“…barriers will delay or prevent drug importation,” say regulatory experts
In this analysis, which was published in Lexology on October 13, 2020, three global regulatory experts examine barriers to drug importation.
[...]Counterfeit Medicine News for the Week of October 5, 2020
In PSM’s round-up this week: Policy truths about drug importation, prosecutions for fake COVID-19 treatments and financial fraud, and another week in counterfeit pills.
[...]US Attorney for Arizona Calls Illicit Fentanyl “The Most Dangerous Drug We Have Confronted as a Nation”
In the first seven months of 2020, the Arizona Department of Health Services reported over 2,700 newly suspected opioid overdose deaths in Arizona. What makes this figure more startling is that there were just over 3,800 suspected opioid deaths in the preceding 30 months. The problem is escalating, and rapidly.
[...]Colorado Health and Human Services Committee hearing on SB 119 – February 13, 2020
On February 13, 2020 the Colorado Senate’s Health and Human Services Committee held a hearing during which a member of the committee asked where the $810,000 to implement drug importation has gone, and what the progress is. His questions, which are directed to head of the agency and the lead importation pharmacist, begin at 6:56.…
[...]Wyoming’s Dept. of Health Recommends The State Not Attempt A Drug Importation Program
Wyoming is one of many states that decided to examine if importing drugs would provide significant savings to its citizens. In a hearing in August and a report released today, they took a critical look at the issue and the Department of Health recommends that the state not pursue the idea for several key reasons…
[...]Counterfeit Medicine News for the Week of September 28, 2020
In PSM’s round-up this week: A new report about the counterfeit medicine trade, fake COVID-19 vaccines in India, the week in counterfeit pills.
[...]Counterfeit Medicine News for the Week of September 21, 2020
In PSM’s round-up this week: HHS defies 20 years of expertise and guidance and recent negative feedback to finalize regulations for state-based Canadian drug importation programs, forward movement on the Safe Therapeutics Act, and more #covidscam and counterfeit drug news.
[...]